NEUROCRINE BIOSCIENCES INC

USReporting entity

Insider

NEUROCRINE BIOSCIENCES INC

USReporting entity

Transactions

Issuers

Buys / Sells

2/0

Last tx

23 Feb 2023

Behaviour

1 purchase reported after at least 12 months of silence — most recent on 23 Feb 2023.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Voyager Therapeutics, Inc.	8,575,316	reported	23 Feb 2023	tx 2+8,575,316

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
23 Feb 2023	PURCHASE	Voyager Therapeutics, Inc.	4,395,588	8.88 USD	first after silence
12 Mar 2019	PURCHASE	Voyager Therapeutics, Inc.	4,179,728	11.96 USD

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
Voyager Therapeutics, Inc.	8,575,316	reported	23 Feb 2023	tx 2+8,575,316